Literature DB >> 31262770

Vaccinating the Patient with ESKD.

Sana F Khan1, Brendan T Bowman2.   

Abstract

Entities:  

Keywords:  ESKD; ESRD; Kidney Failure, Chronic; end stage kidney disease; hepatitis; immune deficiency; risk factors

Year:  2019        PMID： 31262770      PMCID： PMC6777591          DOI： 10.2215/CJN.02210219

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  8 in total

Review 1.  Characteristics and causes of immune dysfunction related to uremia and dialysis.

Authors:  Aline Borsato Hauser; Andréa E M Stinghen; Sawako Kato; Sérgio Bucharles; Carlos Aita; Yukio Yuzawa; Roberto Pecoits-Filho
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

2.  Hepatitis B Reverse Seroconversion and Transmission in a Hemodialysis Center: A Public Health Investigation and Case Report.

Authors:  Sarah Rhea; Anne Moorman; Robert Pace; Victoria Mobley; Jennifer MacFarquhar; Edward Robinson; Tonya Hayden; Hong Thai; Jan Drobeniuc; John T Brooks; Zack Moore; Priti R Patel
Journal:  Am J Kidney Dis       Date:  2016-05-07       Impact factor: 8.860

3.  False-negative hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States.

Authors:  Matthew C Foy; Chloe L Thio; Hyon S Hwang; Melissa Saulynas; James P Hamilton; Derek M Fine; Mohamed G Atta
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

4.  Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.

Authors:  Eduardo Lacson; Ming Teng; Janus Ong; Lori Vienneau; Norma Ofsthun; J Michael Lazarus
Journal:  Hemodial Int       Date:  2005-10       Impact factor: 1.812

5.  Immunogenicity of trivalent influenza vaccines in patients with chronic kidney disease undergoing hemodialysis: MF59-adjuvanted versus non-adjuvanted vaccines.

Authors:  Ji Yun Noh; Joon Young Song; Won Suk Choi; Jacob Lee; Yu Bin Seo; Young Joo Kwon; Gang Jee Ko; Dae Ryong Cha; Young Sun Kang; Young-Ki Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Hum Vaccin Immunother       Date:  2016-11       Impact factor: 3.452

6.  High-Dose Seasonal Influenza Vaccine in Patients Undergoing Dialysis.

Authors:  Dana C Miskulin; Daniel E Weiner; Hocine Tighiouart; Eduardo K Lacson; Klemens B Meyer; Taimur Dad; Harold J Manley
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-23       Impact factor: 8.237

7.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12

8.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.

Authors:  Lisa A Grohskopf; Leslie Z Sokolow; Karen R Broder; Emmanuel B Walter; Alicia M Fry; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2018-08-24
  8 in total
  3 in total

1.  IgG SARS-CoV-2 antibodies persist at least for 10 months in patients on hemodialysis.

Authors:  C Dudreuilh; T Roper; C Breen; P Chowdhury; S Douthwaite; N Kumar; D A Moutzouris
Journal:  Kidney Int Rep       Date:  2021-04-08

2.  Longevity of Humoral Response Six Months Following BNT162b2 Vaccine in Dialysis Patients.

Authors:  Timna Agur; Naomi Ben-Dor; Michal Herman-Edelstein; Tali Steinmetz; Shelly Lichtenberg; Shira Schneider; Dafna Yahav; Benaya Rozen-Zvi; Boris Zingerman
Journal:  Front Med (Lausanne)       Date:  2022-03-25

3.  Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease.

Authors:  Masatoshi Matsunami; Tomo Suzuki; Junko Fukuda; Toshiki Terao; Kohei Ukai; Shinnosuke Sugihara; Takumi Toishi; Kanako Nagaoka; Mayumi Nakata; Mamiko Ohara; Jun Yashima; Hiroshi Kuji; Kosei Matsue
Journal:  Ren Replace Ther       Date:  2022-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.